ALDH7A1 and respiratory system disorder: Lately, there has been a growing interest in selective or dual PDE inhibitors, especially active against the PDE3, PDE4, PDE5, or PDE7 and PDE8 isoforms, as therapeutic targets for respiratory diseases [14,18].